APA

Tsiambas E., Papanikolaou V., Chrysovergis A., Mastronikolis N., Ragos V., Kavantzas N., Lazaris A. C. & Kyrodimos E. (20200915). Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. : Pathology oncology research : POR.

Chicago

Tsiambas Evangelos, Papanikolaou Vasileios, Chrysovergis Aristeidis, Mastronikolis Nicholas, Ragos Vasileios, Kavantzas Nikolaos, Lazaris Andreas C and Kyrodimos Efthymios. 20200915. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. : Pathology oncology research : POR.

Harvard

Tsiambas E., Papanikolaou V., Chrysovergis A., Mastronikolis N., Ragos V., Kavantzas N., Lazaris A. C. and Kyrodimos E. (20200915). Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. : Pathology oncology research : POR.

MLA

Tsiambas Evangelos, Papanikolaou Vasileios, Chrysovergis Aristeidis, Mastronikolis Nicholas, Ragos Vasileios, Kavantzas Nikolaos, Lazaris Andreas C and Kyrodimos Efthymios. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. : Pathology oncology research : POR. 20200915.